Crossmark

ECCO2R and NIV-NAVA for stepwise early weaning in extremely severe COPD patients: a promising solution with details to be defined

Published Online: 2020-01-28

Published Print: 2020-12

Authors

Wang, Heyan http://orcid.org/0000-0003-0797-9234
He, Hangyong
License Information

Text and Data Mining valid from 2020-01-28

Version of Record valid from 2020-01-28
More Information

Article History

Received: 21 December 2019

Accepted: 12 January 2020

First Online: 28 January 2020

Ethics approval and consent to participate

: Not applicable

: Not applicable

: The authors declare that they have no competing interests.

Document is current